how effective is oral glp 1 GLP-1 Pill Delivers Injection-Like Weight Loss Results in Clinical Trials The Growing Impact of Oral

E., Czachor, J

Final Thoughts on Retatrutide vs Semaglutide and Tirzepatide Retatrutide is not a GLP-3 drug

Davies M , 2021, Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2), Lancet 397 10278 4

BMC Med

However, this increased attention has also led to concerns about the availability of these drugs for those who need them most

Risks associated with mass-produced compounded GLP-1s Although the FDA has declared that the supply shortage is resolved, some companies continue to mass produce compounded versions of GLP-1s, claiming that the drugs are personalized for patient needs by altering the method of delivery (e.g., gummy, injection, spray) or adding unnecessary and unproven ingredients like B12 and glycine